# Endothelial Disfunction Treatment With Glimepiride/Metformin Combination (Glimetal) in Type 2 Diabetes Patients

> **NCT01429818** · PHASE4 · COMPLETED · sponsor: **Laboratorios Silanes S.A. de C.V.** · enrollment: 16 (actual)

## Conditions studied

- Endothelial Dysfunction
- Diabetes Mellitus

## Interventions

- **DRUG:** Glimepiride/metformin
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT01429818
- **Lead sponsor:** Laboratorios Silanes S.A. de C.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2011-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01429818

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01429818, "Endothelial Disfunction Treatment With Glimepiride/Metformin Combination (Glimetal) in Type 2 Diabetes Patients". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01429818. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*